Literature DB >> 1699766

Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: usefulness in diagnosis of prostate cancer.

S Veneziano1, P Pavlica, R Querzé, G Nanni, M G Lalanne, F Vecchi.   

Abstract

The authors calculated the volume of the prostate by transrectal ultrasonography and evaluated prostate-specific antigen (PSA) in 108 patients with benign prostatic disease or with clinically suspected carcinoma and in 35 normal subjects. In each case the PSA value was related to the corresponding gland volume (V), which gives a PSA/V index. 32 patients underwent transurethral resection, 23 underwent open prostatectomy and biopsy was performed in 53. Histological examination revealed benign prostatic hyperplasia in 63, prostatitis in 12 and carcinoma in 33. In normal subjects and in those with benign prostatic diseases, the mean PSA/V index was 0.090 and 0.099, respectively. In patients with prostatic carcinoma the ratio was 1.73. The authors propose that this ratio be used, as an alternative to the absolute value of PSA, to differentiate patients with benign and malignant diseases of the prostate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699766     DOI: 10.1159/000463885

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

Review 1.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

2.  The value of prostatic specific antigen density in the early diagnosis of prostate cancer.

Authors:  Ch Deliveliotis; G Louras; P Kyriazis; A Gyftopoulos; L Louka; E Alargof
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: correlation with removed prostate weight.

Authors:  I Alkan; L Türkeri; T Biren; I Cevik; A Akdaş
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

4.  History of the discovery and clinical translation of prostate-specific antigen.

Authors:  William J Catalona
Journal:  Asian J Urol       Date:  2015-04-16

5.  Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions.

Authors:  Antonio C Westphalen; Farhad Fazel; Hao Nguyen; Miguel Cabarrus; Katryana Hanley-Knutson; Katsuto Shinohara; Peter R Carroll
Journal:  Int Braz J Urol       Date:  2019 Jul-Aug       Impact factor: 1.541

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.